Ketamine interactions with biomarkers of stress: A randomized placebo-controlled repeated measures resting-state fMRI and PCASL pilot study in healthy men

Ketamine, an NMDA receptor antagonist, is increasingly used to study the link between glutamatergic signaling dysregulation and mood and chronic pain disorders. Glutamatergic neurotransmission and stress corticosteroids (cortisol in human) are critical for Ca(2+) mediated neuroplasticity and behavioral adaptation. The mechanisms of action of glutamatergic neurotransmission and stress corticosteroids on the NMDA-receptors of the hippocampus have been long investigated in animals, but given little attention in human studies. In this randomized single-blinded placebo-controlled crossover study (12 healthy young men), five sets of resting-state fMRI (RSFMRI), pseudocontinuous arterial spin labeling (PCASL), and corresponding salivary cortisol samples were acquired over 4h, at given intervals under pharmacokinetically-controlled infusion of subanesthetic ketamine (20 & 40mg/70kg/h). An identical procedure was repeated under a sham placebo condition. Differences in the profile of ketamine versus placebo effect over time were examined. Compared to placebo, ketamine mimicked a stress-like response (increased cortisol, reduced calmness and alertness, and impaired working memory). Ketamine effects on the brain included a transient prefrontal hyperperfusion and a dose-related reduction of relative hippocampal perfusion, plus emerging hyperconnectivity between the hippocampus and the occipital, cingulate, precuneal, cerebellar and basal ganglia regions. The spatiotemporal profiles of ketamine effects on different hippocampal subnetworks suggest a topographically dissociable change in corticohippocampal functional connectivity. We discuss our findings in the context of the negative feedback inhibition theory of the hippocampal stress-control. This pilot study provides a methodological framework for multimodal functional neuroimaging under resting-state conditions, which may be generalized for translational studies of glutamatergic- or stress-related etiology of neuropsychiatric disorders.

[1]  Dan V Iosifescu,et al.  Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. , 2013, The American journal of psychiatry.

[2]  Hallvard Røe Evensmoen,et al.  Long-axis specialization of the human hippocampus , 2013, Trends in Cognitive Sciences.

[3]  A Dagher,et al.  Critical involvement of the thalamus and precuneus during restoration of consciousness with physostigmine in humans during propofol anaesthesia: a positron emission tomography study. , 2011, British journal of anaesthesia.

[4]  Thomas E. Nichols,et al.  Nonparametric permutation tests for functional neuroimaging: A primer with examples , 2002, Human brain mapping.

[5]  Johannes Berkhof,et al.  Cortisol Responses to Daily Events in Major Depressive Disorder , 2003, Psychosomatic medicine.

[6]  Florian Holsboer,et al.  Resting state functional MRI connectivity predicts hypothalamus-pituitary-axis status in healthy males , 2013, Psychoneuroendocrinology.

[7]  Rebecca Elliott,et al.  Detection of the acute effects of hydrocortisone in the hippocampus using pharmacological fMRI , 2012, European Neuropsychopharmacology.

[8]  S. Dickerson,et al.  Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. , 2004, Psychological bulletin.

[9]  P. Sawchenko,et al.  A Common Substrate for Prefrontal and Hippocampal Inhibition of the Neuroendocrine Stress Response , 2011, The Journal of Neuroscience.

[10]  Albert Dahan,et al.  Spatial heterogeneity of the relation between resting‐state connectivity and blood flow: An important consideration for pharmacological studies , 2014, Human brain mapping.

[11]  B. McEwen,et al.  Protective and damaging effects of stress mediators: central role of the brain , 2006, Dialogues in clinical neuroscience.

[12]  H. Eichler,et al.  Comparison of the Effects of Ketamine and Memantine on Prolactin and Cortisol Release in Men: A Randomized, Double-blind, Placebo-controlled Trial , 2001, Neuropsychopharmacology.

[13]  M. Segal,et al.  Striking Variations in Corticosteroid Modulation of Long-Term Potentiation along the Septotemporal Axis of the Hippocampus , 2007, The Journal of Neuroscience.

[14]  J. R. Baker,et al.  The hippocampal formation participates in novel picture encoding: evidence from functional magnetic resonance imaging. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Michael K Parides,et al.  Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. , 2014, JAMA psychiatry.

[16]  B. Kudielka,et al.  Salivary cortisol as a biomarker in stress research , 2009, Psychoneuroendocrinology.

[17]  Ilya M. Veer,et al.  Endogenous cortisol is associated with functional connectivity between the amygdala and medial prefrontal cortex , 2012, Psychoneuroendocrinology.

[18]  James P. Herman,et al.  Limbic system mechanisms of stress regulation: Hypothalamo-pituitary-adrenocortical axis , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[19]  J. Detre,et al.  Perfusion functional MRI reveals cerebral blood flow pattern under psychological stress. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  G. York,et al.  Congenital and Acquired Cognitive Disorders , 1981, Neurology.

[21]  S. Williams,et al.  Quantifying the Attenuation of the Ketamine Pharmacological Magnetic Resonance Imaging Response in Humans: A Validation Using Antipsychotic and Glutamatergic Agents , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[22]  H A Callis,et al.  The General Adaptation Syndrome. , 1950, Journal of the National Medical Association.

[23]  Albert Dahan,et al.  Effect of Subanesthetic Ketamine on Intrinsic Functional Brain Connectivity: A Placebo-controlled Functional Magnetic Resonance Imaging Study in Healthy Male Volunteers , 2012, Anesthesiology.

[24]  Matthew J. Brookes,et al.  Measuring functional connectivity using MEG: Methodology and comparison with fcMRI , 2011, NeuroImage.

[25]  C. Wellman,et al.  NMDA receptor blockade alters stress-induced dendritic remodeling in medial prefrontal cortex. , 2011, Cerebral cortex.

[26]  Carol A. Tamminga,et al.  Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia , 2005, Psychiatry Research: Neuroimaging.

[27]  Robert M. Sapolsky,et al.  Glucocorticoid endangerment of hippocampal neurons is NMDA-receptor dependent , 1990, Brain Research.

[28]  A. Bond,et al.  The use of analogue scales in rating subjective feelings , 1974 .

[29]  David C. Glahn,et al.  Acute effects of hydrocortisone on the human brain: An fMRI study , 2010, Psychoneuroendocrinology.

[30]  Shane McKie,et al.  Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study. , 2008, Archives of general psychiatry.

[31]  Tracy Warbrick,et al.  Ketamine effects on brain function — Simultaneous fMRI/EEG during a visual oddball task , 2011, NeuroImage.

[32]  Colleen K. Loo,et al.  Long-Lasting Effects of a Single Subcutaneous Dose of Ketamine for Treating Melancholic Depression: A Case Report , 2014, Biological Psychiatry.

[33]  Leonardo Nogueira,et al.  Effects of (-)-epicatechin on molecular modulators of skeletal muscle growth and differentiation. , 2014, The Journal of nutritional biochemistry.

[34]  S. Thuret,et al.  Why looking at the whole hippocampus is not enough—a critical role for anteroposterior axis, subfield and activation analyses to enhance predictive value of hippocampal changes for Alzheimer’s disease diagnosis , 2014, Front. Cell. Neurosci..

[35]  Arne Nagels,et al.  Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency , 2012, European Archives of Psychiatry and Clinical Neuroscience.

[36]  E. Benarroch,et al.  NMDA receptors , 2011, Neurology.

[37]  Andre F. Marquand,et al.  Test–retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers , 2013, NeuroImage.

[38]  Michael J Meaney,et al.  The influence of anxiety and depressive symptoms during pregnancy on birth size. , 2014, Paediatric and perinatal epidemiology.

[39]  Rasmus M. Birn,et al.  The role of physiological noise in resting-state functional connectivity , 2012, NeuroImage.

[40]  Michael J Meaney,et al.  Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health. , 2007, Trends in molecular medicine.

[41]  Zhen Yan,et al.  The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission , 2011, Nature Reviews Neuroscience.

[42]  Anthony G. Hudetz,et al.  Increased precuneus connectivity during propofol sedation , 2014, Neuroscience Letters.

[43]  B. McEwen,et al.  ABNORMAL CORTISOL RESPONSE IN ALZHEIMER'S DISEASE LINKED TO HIPPOCAMPAL ATROPHY , 1988, The Lancet.

[44]  Georg Northoff,et al.  NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI , 2005, Schizophrenia Research.

[45]  N. McNaughton The role of the subiculum within the behavioural inhibition system , 2006, Behavioural Brain Research.

[46]  C. Stevens,et al.  NMDA and non-NMDA receptors are co-localized at individual excitatory synapses in cultured rat hippocampus , 1989, Nature.

[47]  G. McCarthy,et al.  Relationship of Resting Brain Hyperconnectivity and Schizophrenia-like Symptoms Produced by the NMDA receptor Antagonist Ketamine in Humans , 2012, Molecular Psychiatry.

[48]  D. Mohr,et al.  Depression and cortisol responses to psychological stress: A meta-analysis , 2005, Psychoneuroendocrinology.

[49]  A. Malhotra,et al.  Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. , 1997, The American journal of psychiatry.

[50]  H. Holcomb,et al.  Effects of Noncompetitive NMDA Receptor Blockade on Anterior Cingulate Cerebral Blood Flow in Volunteers with Schizophrenia , 2005, Neuropsychopharmacology.

[51]  C. Kirschbaum,et al.  Salivary cortisol in psychobiological research: an overview. , 1989, Neuropsychobiology.

[52]  J. Morrison,et al.  The Brain on Stress: Vulnerability and Plasticity of the Prefrontal Cortex over the Life Course , 2013, Neuron.

[53]  M. Joëls,et al.  Brain corticosteroid receptor balance in health and disease. , 1998, Endocrine reviews.

[54]  A. Dahan,et al.  Influence of ketamine and morphine on descending pain modulation in chronic pain patients: a randomized placebo-controlled cross-over proof-of-concept study. , 2013, British journal of anaesthesia.

[55]  Menno P. Witter,et al.  A pathophysiological framework of hippocampal dysfunction in ageing and disease , 2011, Nature Reviews Neuroscience.

[56]  S. Southwick,et al.  Glutamate and post-traumatic stress disorder: toward a psychobiology of dissociation. , 1999, Seminars in clinical neuropsychiatry.

[57]  D. Luckenbaugh,et al.  Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds. , 2014, Annual review of pharmacology and toxicology.

[58]  F. Seguin,et al.  Effects of stress throughout the lifespan on the brain, behaviour and cognition , 2009 .

[59]  Marieke Niesters,et al.  Population pharmacokinetic—pharmacodynamic modeling of ketamine‐induced pain relief of chronic pain , 2011, European journal of pain.

[60]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[61]  Peter Seres,et al.  Structural changes in the hippocampus in major depressive disorder: contributions of disease and treatment. , 2010, Journal of psychiatry & neuroscience : JPN.

[62]  David C Rowland,et al.  Potential Anatomical Basis for Attentional Modulation of Hippocampal Neurons , 2008, Annals of the New York Academy of Sciences.

[63]  Xiao-Jing Wang,et al.  NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia , 2012, Proceedings of the National Academy of Sciences.

[64]  Katharina Henke,et al.  Glucocorticoid‐induced impairment of declarative memory retrieval is associated with reduced blood flow in the medial temporal lobe , 2003, The European journal of neuroscience.

[65]  M. Meaney,et al.  The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[66]  M. van Buchem,et al.  Can arterial spin labeling detect white matter perfusion signal? , 2009, Magnetic resonance in medicine.

[67]  P. Albert,et al.  Models for longitudinal data: a generalized estimating equation approach. , 1988, Biometrics.

[68]  Michael J. Cousins,et al.  Ketamine in Chronic Pain Management: An Evidence-Based Review , 2003, Anesthesia and analgesia.

[69]  Bita Moghaddam,et al.  Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex , 1997, The Journal of Neuroscience.

[70]  Stephen M. Smith,et al.  Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference , 2009, NeuroImage.

[71]  P. Boesiger,et al.  Ketamine Decreases Resting State Functional Network Connectivity in Healthy Subjects: Implications for Antidepressant Drug Action , 2012, PloS one.

[72]  Richard J. Davidson,et al.  Subgenual Prefrontal Cortex Activity Predicts Individual Differences in Hypothalamic-Pituitary-Adrenal Activity Across Different Contexts , 2010, Biological Psychiatry.

[73]  John R Geddes,et al.  Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic , 2014, Journal of psychopharmacology.

[74]  F. Zitman,et al.  Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. , 2009, Archives of general psychiatry.

[75]  T. Hendler,et al.  Neural traces of stress: cortisol related sustained enhancement of amygdala-hippocampal functional connectivity , 2013, Front. Hum. Neurosci..

[76]  Ilya M. Veer,et al.  The impact of “physiological correction” on functional connectivity analysis of pharmacological resting state fMRI , 2013, NeuroImage.

[77]  Paul J. Harrison,et al.  Glutamate Receptors and Transporters in the Hippocampus in Schizophrenia , 2003, Annals of the New York Academy of Sciences.

[78]  R. Cameron Craddock,et al.  A comprehensive assessment of regional variation in the impact of head micromovements on functional connectomics , 2013, NeuroImage.

[79]  Melly S. Oitzl,et al.  Brain development under stress: Hypotheses of glucocorticoid actions revisited , 2010, Neuroscience & Biobehavioral Reviews.

[80]  Marian Joëls,et al.  Corticosteroid hormones in the central stress response: Quick-and-slow , 2008, Frontiers in Neuroendocrinology.

[81]  David Borsook,et al.  CNS Measures of Pain Responses Pre- and Post-Anesthetic Ketamine in a Patient with Complex Regional Pain Syndrome. , 2015, Pain medicine.

[82]  Jens C. Pruessner,et al.  Deactivation of the Limbic System During Acute Psychosocial Stress: Evidence from Positron Emission Tomography and Functional Magnetic Resonance Imaging Studies , 2008, Biological Psychiatry.

[83]  R. Kahn,et al.  The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects , 1998, Psychopharmacology.

[84]  Maura L. Furey,et al.  Human Biomarkers of Rapid Antidepressant Effects , 2013, Biological Psychiatry.

[85]  D. Rosielle,et al.  Psychiatry , 1905, NeuroImage.

[86]  Catherine Lord,et al.  Stress response in postpartum women with and without obsessive-compulsive symptoms: an fMRI study. , 2012, Journal of psychiatry & neuroscience : JPN.

[87]  R. Sapolsky,et al.  Glucocorticoid endangerment of the hippocampus: tissue, steroid and receptor specificity. , 1990, Neuroendocrinology.

[88]  Steven M. Southwick,et al.  Smaller head of the hippocampus in Gulf War-related posttraumatic stress disorder , 2005, Psychiatry Research: Neuroimaging.

[89]  B. McEwen,et al.  Selective Retention of Corticosterone by Limbic Structures in Rat Brain , 1968, Nature.

[90]  Peter Herscovitch,et al.  Neural Correlates of Rapid Antidepressant Response to Ketamine in Treatment-Resistant Unipolar Depression: A Preliminary Positron Emission Tomography Study , 2013, Biological Psychiatry.

[91]  Najmeh Khalili-Mahani,et al.  Hippocampal activation during a cognitive task is associated with subsequent neuroendocrine and cognitive responses to psychological stress , 2009, Hippocampus.

[92]  B. McEwen Stress and hippocampal plasticity. , 1999, Annual review of neuroscience.

[93]  Ronald S Duman,et al.  New paradigms for treatment‐resistant depression , 2013, Annals of the New York Academy of Sciences.

[94]  Marian Joëls,et al.  Rapid non-genomic effects of corticosteroids and their role in the central stress response. , 2011, The Journal of endocrinology.

[95]  Erik Olofsen,et al.  An observational study on the effect of S(+)‐ketamine on chronic pain versus experimental acute pain in Complex Regional Pain Syndrome type 1 patients , 2010, European journal of pain.

[96]  David R. Anderson,et al.  Model selection and multimodel inference : a practical information-theoretic approach , 2003 .

[97]  G. Ferri,et al.  Volumetric MRI analysis of hippocampal subregions in Cushing's disease: A model for glucocorticoid neural modulation , 2011, European Psychiatry.

[98]  B. McEwen Protective and damaging effects of stress mediators: central role of the brain , 2006, Dialogues in clinical neuroscience.

[99]  Richard Rogers,et al.  An Investigation to Dissociate the Analgesic and Anesthetic Properties of Ketamine Using Functional Magnetic Resonance Imaging , 2004, Anesthesiology.

[100]  J. Xuereb,et al.  The messenger RNAs for the N-methyl- d-aspartate receptor subunits show region-specific expression of different subunit composition in the human brain , 1996, Neuroscience.

[101]  James P. Herman,et al.  Role of the ventral subiculum in stress integration , 2006, Behavioural Brain Research.

[102]  J. Olney,et al.  Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.

[103]  Dick J. Veltman,et al.  Glucocorticoids Decrease Hippocampal and Prefrontal Activation during Declarative Memory Retrieval in Young Men , 2007, Brain Imaging and Behavior.

[104]  O. Manzoni,et al.  Acute Stress Facilitates Hippocampal CA1 Metabotropic Glutamate Receptor-Dependent Long-Term Depression , 2007, The Journal of Neuroscience.

[105]  S. Lupien,et al.  The effects of stress and stress hormones on human cognition: Implications for the field of brain and cognition , 2007, Brain and Cognition.

[106]  J. P. Hamilton,et al.  Stress-induced activation of the HPA axis predicts connectivity between subgenual cingulate and salience network during rest in adolescents. , 2011, Journal of child psychology and psychiatry, and allied disciplines.

[107]  F. Vollenweider,et al.  Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG) , 1997, European Neuropsychopharmacology.

[108]  Marian Joëls,et al.  Version unknown SOURCE ( OR PART OF THE FOLLOWING SOURCE ) : Type article Title Corticosterone alters AMPAR mobility and facilitates bidirectional synaptic plasticity , 2009 .

[109]  Paul M. Matthews,et al.  Functional segmentation of the hippocampus in the healthy human brain and in Alzheimer's disease , 2013, NeuroImage.